- Home
- ASND vs WY Comparison
ASND vs WY Comparison
Compare ASND & WY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | WY |
|---|---|---|
| Founded | 2006 | 1900 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.7B | 15.3B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ASND | WY |
|---|---|---|
| Price | $227.04 | $19.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 7 |
| Target Price | ★ $281.50 | $28.86 |
| AVG Volume (30 Days) | 736.0K | ★ 5.4M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $6,905,000,000.00 |
| Revenue This Year | $96.35 | $5.78 |
| Revenue Next Year | $44.91 | $8.94 |
| P/E Ratio | ★ N/A | $44.63 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $186.05 | $19.55 |
| 52 Week High | $282.15 | $27.75 |
Technical Indicators
Market Signals| Indicator | ASND | WY |
|---|---|---|
| Relative Strength Index (RSI) | 37.16 | 20.58 |
| Support Level | $213.28 | N/A |
| Resistance Level | $246.56 | $25.14 |
| Average True Range (ATR) | 9.61 | 0.51 |
| MACD | -2.67 | -0.19 |
| Stochastic Oscillator | 14.38 | 2.83 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
About WY Weyerhaeuser Company
Weyerhaeuser Co ranks among the world's key forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.